Olsson, A <br/><br/>
Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Oct 2015 
 - 1557-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-0970 
<br/><br/><label>Standard No.: </label>10.1177/1352458514566417  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorptiometry, Photon<br/>Adult<br/>Age Factors<br/>Aged<br/>Body Mass Index<br/>Bone Density--drug effects<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Chronic Progressive--blood<br/>Multiple Sclerosis, Relapsing-Remitting--blood<br/>Severity of Illness Index<br/>Young Adult